Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04718961 |
| Consolidated Lead Sponsor | Mirum Pharmaceuticals |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 4 participants (ACTUAL) |
| Registered Start Date | 2021-01-04 |
| WhyStopped Classification | Insufficient / Slow Accrual |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Alabama at Birmingham | Birmingham, AL | Open Hospital Dossier -> |
| Yale Cancer Center and Smilow Cancer Hospital | New Haven, CT | Open Hospital Dossier -> |
| University of Miami | Miami, FL | Open Hospital Dossier -> |
| Ohio State University Comprehensive Cancer Center | Columbus, OH | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.